Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma

NCT00379262 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

803

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Capecitabine
DRUG: Adjuvant chemotherapy using PF (5-Fluorouracil )
DRUG: Induction chemotherapy using PF (5-Fluorouracil)

Sponsor

Hong Kong Nasopharyngeal Cancer Study Group Limited

Collaborators

[object Object]
[object Object]